Kura Oncology to Present at the 2015 Wedbush PacGrow Healthcare Conference
05 août 2015 07h30 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and...
Kura Oncology to Present at the Jefferies 2015 Global Healthcare Conference
27 mai 2015 07h30 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and...
First Patient Dosed in Phase 2 Study of Tipifarnib in Advanced Cancers With HRAS Mutations
18 mai 2015 08h00 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., May 18, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. ("Kura Oncology" or the "Company"), a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for...
Faheem Hasnain Joins Kura Oncology Board of Directors
27 avr. 2015 08h00 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., April 27, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. ("Kura Oncology" or the "Company"), a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for...
Kura Oncology's Menin-MLL Inhibitor Program Shows Promise in Study Published in Cancer Cell; Program Targeting Acute Leukemias Licensed From University of Michigan
30 mars 2015 11h00 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., March 30, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. ("Kura Oncology" or the "Company"), a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for...
Kura Oncology Announces License Agreement With Janssen Pharmaceutica for Development and Commercialization of Tipifarnib; Closes $60 Million Private Placement and Completes Reverse Merger
12 mars 2015 07h30 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., March 12, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. ("Kura Oncology" or the "Company"), a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for...